Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants

Completed · Early Phase 1

Conditions studied: Pharmacokinetics

In brief

This will be an open-label, randomized, 3-treatment, 2-period, 2-sequence study in healthy subjects to evaluate the single-dose PK of milademetan when given as monotherapy and when administered with steady-state levels of the strong CYP3A4 inhibitors itraconazole or posaconazole. The duration of the study for each individual subject will be approximately 49 days from the start of Screening through Study Discharge. Subjects will remain in-house for up to 23 days, including 22 overnight stays.

Key facts

Study ID

NCT03614455

Run by

Daiichi Sankyo

People needed

36

Starts

2018-07-13

Expected to finish

2018-10-01

Last updated by the study team

2019-02-12

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Has negative urine test for drugs of abuse, alcohol and tobacco
• If female, is surgically sterile or postmenopausal
• If male, agrees to protocol-defined contraceptive methods
• Has adequate hematologic, hepatic, and renal function as defined by the protocol
• Is able and willing to follow all study procedures
• Has provided a signed informed consent

You may not qualify if…

• Is female who is pregnant or breastfeeding
• Is unable to swallow oral medication
• Is unable to follow study procedures
• Has creatinine clearance < 90 mL/min at screening
• Is taking or has taken any medications or therapies outside of protocol-defined parameters
• Has history of or a known allergic reaction to azole antifungal agents
• Has any disease or condition that, per protocol or in the opinion of the investigator, might affect:
• safety and well-being of the participant or offspring
• safety of study staff

Where it is running

• Covance Clinical Research Unit, Inc. — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.